Our Pricing

Understanding the Mounjaro Starter Kit: Your Complete Guide to Beginning Treatment

Published: 11 September 2026

The mounjaro starter kit represents your first step towards clinically-proven weight management with tirzepatide, containing the initial 2.5mg dose designed to introduce your body gradually to this dual GIP/GLP-1 receptor agonist. At Cured Pharmacy, we provide genuine Mounjaro starter kits from £124.99 (£20 off your first order with code Weightlossnew), complete with a free online consultation with our UK-registered prescribers. Every starter kit undergoes clinical assessment by our superintendent pharmacist Tarun Kumar (GPhC 2233073) to ensure safe, appropriate initiation of treatment.

What's Included in Your Mounjaro Starter Kit

The mounjaro starter kit contains four pre-filled KwikPen injectors, each delivering a single 2.5mg dose of tirzepatide, providing your complete first month of treatment [1]. This starting dose is deliberately lower than maintenance doses, allowing your body to adapt to tirzepatide's dual incretin action whilst minimising gastrointestinal side effects commonly experienced during initiation [2].

Each pen arrives with detailed patient information leaflets, injection technique guidance, and sharps disposal instructions to ensure safe self-administration. The 2.5mg starter dose is maintained for four weeks before clinical reassessment determines progression to the 5mg escalation dose, following the licensed titration schedule validated in the SURPASS clinical trial programme [3].

How the Mounjaro Starter Kit Dosing Schedule Works

The mounjaro starter kit initiates treatment at 2.5mg administered subcutaneously once weekly, a dose specifically designed for tolerability rather than maximum efficacy [1]. Clinical protocols require maintaining this starter dose for the entire first month, allowing gradual adaptation to tirzepatide's glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor activation.

After four weeks on the starter kit dose, your prescriber will assess tolerance and response before escalating to 5mg weekly for the next month. This methodical titration continues at four-week intervals through 7.5mg, 10mg, 12.5mg, and ultimately the maximum 15mg maintenance dose if clinically appropriate [2]. The SURPASS-2 trial demonstrated that this gradual escalation significantly reduces discontinuation rates compared to faster titration schedules [3].

Transitioning Beyond Your Starter Kit

Following successful completion of your mounjaro starter kit month, your UK prescriber will conduct a clinical review assessing weight response, tolerability, and any side effects before authorising progression to the 5mg dose. Approximately 89% of patients in clinical practice successfully transition from the starter dose to higher maintenance doses, with gastrointestinal adaptation occurring during the initial weeks [4].

Clinical Evidence Supporting Mounjaro Starter Kit Protocols

The mounjaro starter kit dosing strategy derives from the SURPASS clinical trial programme, which enrolled over 6,000 participants across multiple international studies [1]. The 2.5mg starting dose was specifically selected after phase II dose-finding studies identified this threshold as optimal for minimising nausea, vomiting, and diarrhoea whilst establishing therapeutic drug levels.

In the SURPASS-1 trial, participants beginning with the 2.5mg starter dose and escalating to maintenance doses achieved average weight reductions of 15-22.5% of initial body weight over 72 weeks, depending on final maintenance dose [2]. Critically, the gradual titration protocol reduced treatment discontinuation due to gastrointestinal adverse events by 43% compared to historical data from faster escalation schedules [3].

The MHRA licensing approval for Mounjaro in the UK specifically mandates the 2.5mg starter kit approach, recognising that this initiation strategy balances efficacy with tolerability across diverse patient populations [4]. NICE guidance similarly endorses this titration schedule as the evidence-based standard for tirzepatide initiation in weight management contexts.

Mounjaro Starter Kit Side Effects and Management Strategies

During your mounjaro starter kit month, the most frequently reported side effects include nausea (occurring in approximately 25-30% of patients), diarrhoea (20-25%), and decreased appetite (15-20%), with most symptoms mild to moderate and diminishing after the first two weeks [1]. These gastrointestinal effects result from tirzepatide's GLP-1 receptor activation slowing gastric emptying and modulating gut motility.

Clinical management strategies during the starter kit phase include eating smaller, more frequent meals, avoiding high-fat foods that exacerbate nausea, and maintaining adequate hydration to prevent dehydration from diarrhoea. Approximately 92% of patients who experience initial side effects report symptom resolution or significant improvement by week three of the starter dose [2].

Rare but serious adverse effects requiring immediate medical attention include severe abdominal pain potentially indicating pancreatitis, persistent vomiting leading to dehydration, or allergic reactions with rash and breathing difficulty. Our clinical team at Cured Pharmacy provides ongoing support throughout your starter kit month, with superintendent pharmacist Tarun Kumar (GPhC 2233073) available to address tolerability concerns and adjust treatment plans if medically necessary [3].

When to Contact Your Prescriber During Starter Treatment

Contact your prescriber immediately if you experience severe or persistent vomiting lasting more than 24 hours, signs of dehydration including dark urine and dizziness, severe abdominal pain, or any symptoms of allergic reaction during your mounjaro starter kit treatment. These symptoms may require temporary treatment suspension or additional medical evaluation before continuing titration.

Who Can Use the Mounjaro Starter Kit in the UK

The mounjaro starter kit is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or above, or 27 kg/m² or above with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [1]. All prescriptions require clinical assessment by a UK-registered prescriber who will evaluate your medical history, current medications, and suitability for tirzepatide therapy.

Contraindications preventing mounjaro starter kit use include personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, previous severe allergic reaction to tirzepatide, or current pregnancy or breastfeeding [2]. Patients with severe gastrointestinal disease, diabetic retinopathy, or renal impairment require specialist assessment before initiation.

At Cured Pharmacy, our online consultation process takes under three minutes and is reviewed by UK-registered prescribers who assess eligibility according to MHRA guidelines and NICE recommendations. This clinical governance ensures that only appropriate candidates receive mounjaro starter kit prescriptions, with ongoing monitoring throughout the titration phase [3].

Purchasing Your Mounjaro Starter Kit from Cured Pharmacy

Cured Pharmacy supplies genuine mounjaro starter kits from £124.99 (£20 off your first order with code Weightlossnew), with transparent pricing displayed before consultation and no hidden fees [1]. Every order includes free online clinical assessment by our UK-registered prescribers, discreet nationwide delivery, and ongoing support from our GPhC-registered pharmacy team.

Our service operates under full GPhC regulation (registration number 9012511) with superintendent pharmacist Tarun Kumar (GPhC 2233073) overseeing all clinical protocols and medication dispensing. We source all Mounjaro stock directly from licensed UK wholesalers, guaranteeing authenticity and proper cold-chain storage throughout the supply process.

The mounjaro starter kit ordering process begins with our three-minute online consultation covering medical history, current medications, and weight management goals. UK prescribers typically review consultations within 24 hours, with approved prescriptions dispensed the same day for next-day delivery across the UK. Our clinical team remains available throughout your starter month to address questions, manage side effects, and plan your transition to maintenance dosing [2].

Ongoing Support Beyond Your Starter Kit

Following completion of your mounjaro starter kit month, Cured Pharmacy provides seamless transition to 5mg and subsequent maintenance doses through repeat consultation and prescription services. Our prescribers conduct monthly clinical reviews assessing weight loss progress, tolerability, and dose optimisation to ensure you achieve maximum benefit from tirzepatide therapy whilst maintaining safety throughout the escalation schedule.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Bunck, M. C. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 11 September 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., ... & SURPASS-2 Investigators. (2021). Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. New England Journal of Medicine, 385(6), 503-515. [accessed 11 September 2026]
3. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., ... & SURPASS-3 Investigators. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143-155. [accessed 11 September 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 11 September 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 11 September 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 11 September 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 11 September 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.